At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 21 enrolled
Drug / intervention
Systane Completedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
In Brief
A Phase 4 clinical trial evaluating Systane Complete for Evaporative Dry Eye. Completed, enrolled 21 participants across 1 site.
Detailed Summary
The objective of the study is to compare the rate of tear evaporation, measured with a novel evaporimeter, before and for one hour after an eye drop containing nano-sized oil droplets has been instilled.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEvaporative Dry Eye
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartNov 2019
Primary CompletionFeb 2020
TodayJul 2026
First PostedSep 17, 2019
Enrollment StartNov 21, 2019
Primary CompletionFeb 6, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.8 years ago
Interventions
Systane Completedrug
Systane Complete will be instilled and rate of evaporation assessed before and after.